View this API's:

Patents at Patent & Trademark Office Patent/Exclusivity data file Drug Approval Drug Safety Freedom of Information Federal Register pages Pharma Companies Pharmacopeial Information Preferred API Supplier (Clients Only)

FDA Approval Activities for this Drug… Trasylol (aprotinin) Injection, Bayer Pharmaceutical Division NDA 20-304/SE1-004 8/28/98 9/1/98 9/1/98 7/2/99 Trasylol Indication: Trasylol is indicated for prophylactic use to reduce perioperative blood loss and the need for blood transfusion in patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery.   For the latest approval information, locate this drug using this index.